These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31138598)

  • 1. Acute generalised skin rash secondary to the Nystatin Oral Suspension.
    Sahu KK; Mishra AK; Lal A; Gandhi R
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31138598
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed hypersensitivity to oral nystatin.
    Martínez FV; Muñoz Pamplona MP; García EC; Urzaiz AG
    Contact Dermatitis; 2007 Sep; 57(3):200-1. PubMed ID: 17680880
    [No Abstract]   [Full Text] [Related]  

  • 3. Type IV hypersensitivity to oral nystatin.
    Barranco R; Tornero P; de Barrio M; de Frutos C; Rodríguez A; Rubio M
    Contact Dermatitis; 2001 Jul; 45(1):60. PubMed ID: 11422284
    [No Abstract]   [Full Text] [Related]  

  • 4. ["Acute generalized exanthematic pustulosis induced by nystatin"].
    Przybilla B; Ruëff F
    Hautarzt; 1999 Feb; 50(2):136-8. PubMed ID: 10097958
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute generalized exanthematous pustulosis, induced by nystatin].
    Rosenberger A; Tebbe B; Treudler R; Orfanos CE
    Hautarzt; 1998 Jun; 49(6):492-5. PubMed ID: 9675578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants.
    Goins RA; Ascher D; Waecker N; Arnold J; Moorefield E
    Pediatr Infect Dis J; 2002 Dec; 21(12):1165-7. PubMed ID: 12506950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.
    Mukherjee PK; Chen H; Patton LL; Evans S; Lee A; Kumwenda J; Hakim J; Masheto G; Sawe F; Pho MT; Freedberg KA; Shiboski CH; Ghannoum MA; Salata RA;
    AIDS; 2017 Jan; 31(1):81-88. PubMed ID: 27677161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late reaction to oral nystatin: the importance of patch testing.
    de la Borbolla JM; Goikoetxea MJ; Cabrera-Freitag P; Gastaminza G
    J Investig Allergol Clin Immunol; 2009; 19(4):321-2. PubMed ID: 19639730
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical Antimycotics for Oral Candidiasis in Warfarin Users.
    Hellfritzsch M; Pottegård A; Pedersen AJ; Burghle A; Mouaanaki F; Hallas J; Grove EL; Damkier P
    Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):368-372. PubMed ID: 27901310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic reaction to nystatin.
    Cooper SM; Reed J; Shaw S
    Contact Dermatitis; 1999 Dec; 41(6):345-6. PubMed ID: 10617220
    [No Abstract]   [Full Text] [Related]  

  • 11. Concomitant sensitization to inhaled budesonide and oral nystatin presenting as allergic contact stomatitis and systemic allergic contact dermatitis.
    Vega F; Ramos T; Las Heras P; Blanco C
    Cutis; 2016 Jan; 97(1):24-7. PubMed ID: 26919353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute generalized exanthematous pustulosis induced by drugs with low-digestive absorption: acarbose and nystatin].
    Poszepczynska-Guigné E; Viguier M; Assier H; Pinquier L; Hochedez P; Dubertret L
    Ann Dermatol Venereol; 2003 Apr; 130(4):439-42. PubMed ID: 12843856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nystatin pastilles and suspension in the treatment of oral candidosis.
    Millns B; Martin MV
    Br Dent J; 1996 Sep; 181(6):209-11. PubMed ID: 8885454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospective comparison of miconazole gel and nystatin suspension in the treatment of oral candidiasis].
    Schaad UB; Bachmann D
    Schweiz Med Wochenschr; 1983 Sep; 113(38):1356-62. PubMed ID: 6356343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis.
    Lyu X; Zhao C; Yan ZM; Hua H
    Drug Des Devel Ther; 2016; 10():1161-71. PubMed ID: 27042008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
    Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
    J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent hiccups: an unusual presentation and treatment.
    Usta Y
    J Pain Symptom Manage; 2012 Feb; 43(2):e7-8. PubMed ID: 22248794
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group.
    Hoppe JE
    Pediatr Infect Dis J; 1997 Mar; 16(3):288-93. PubMed ID: 9076817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe vulvovaginitis associated with intravaginal nystatin therapy.
    Dan M
    Am J Obstet Gynecol; 2001 Jul; 185(1):254-5. PubMed ID: 11483943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases.
    Küchler A; Hamm H; Weidenthaler-Barth B; Kämpgen E; Bröcker EB
    Br J Dermatol; 1997 Nov; 137(5):808-11. PubMed ID: 9415247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.